Skip to main content
Home
  • About us
    • Physiological Relevance
    • High Content Screening
    • Contact Us
  • Assay Development and Screening
    • Know-How
    • Cellular Models
      • MyoScreen™
      • OncoSpheres™
      • Cardiomyocytes
      • Hepatocytes
      • Renal Proximal Tubules
    • ReferenceCell™
    • HCS Facility
    • Workflow
    • Working Together
  • Cell-Based assays
    • Muscular Atrophy/Hypertrophy
    • OncoSpheres™ Drug Profiling
  • Micropattern Products
    • Chips
      • Standard Chips
      • Starter Chips
      • Motility Chips
      • Arena Chips
      • Custom Chips
    • Plates
      • Standard Plates
      • Starter Plates
      • Motility Plates
      • Custom Plates
    • Accessories
    • FAQ
  • Resource Center
    • Technology Overview
    • Publications
image 0

Physiological Assays

Physical cues restituted to the cells for a
restored mature phenotype.

More
image 1

Fully Compatible with HCS

Multiplexed visual read-outs.
High throughput. Assay robustness.

More
image 2

Innovative Read-Outs

Experience the RefCell™ for                                                   Cell contractility, Cell elasticity.                    

More
Cardiomyocytes

Discover a higher level of maturation of human iPS- derived cardiomyocytes.

read more
OncoSpheres™

Discover an robust 3D spheroid cellular model fully compatible with HCS.

read more
MyoScreen™

Discover a first-in-class myotube model by fully maturing human primary myoblasts.

read more
Renal Proximal Tubules

Discover a first-in-class kidney proximal tube model with in vivo like characteristics. 

read more

Events

15

Sep

2nd Annual SBI2 Conference
09

Sep

45TH ANNUAL ESDR MEETING
15

Jun

BIO International Convention

News

05

Apr

CYTOO’s partner Astellas Gene Therapies to present results of an AGT/ CYTOO collaboration on clinical candidate selection to treat DMD at the 2nd Gene Therapy for Muscular Disorders Summit
28

Feb

CYTOO and AskBio enter into research agreement to screen gene therapy candidates for rare muscle disorder
23

Oct

Axcella Enters into Collaboration with CYTOO to Explore Impact of Dysregulated Metabolism on Muscle Physiology

Quick Links

  • Physiological Relevance
  • OncoSpheres™ Drug Profiling
  • Muscular Atrophy/Hypertrophy
  • News
  • Events

Navigation

  • SiteMap
  • Careers
  • Distributors

Subscribe

Read more about subscription
The information collected through this form is recorded and transmitted to the relevant departments of CYTOO, and allows us to send you our newsletter concerning the services we offer. The legal basis for the processing is consent. The data collected is kept as long as you do not unsubscribe from our newsletter via the unsubscribe link under our newsletters [indicate the format of storage]. You have the right of access, rectification, opposition, limitation of processing, and erasure. To learn more about the use of your data and your rights under the amended Data Protection Act and the GDPR, please consult our data protection policy or contact us at rgpd@cytoo.com

Follow Us

Contact us

CYTOO Inc.

185 Alewife Brook Parkway, suite 210

Cambridge, MA 02138

USA

2.5.0.0

CYTOO SA

Headquarter

7 parvis Louis Néel, CS 20050

BHT - Bât. 52

38040 Grenoble cedex 9

Phone : +33 (0)4 38 88 47 05

© 2014 CYTOO SA. All rights reserved
Logo ✕

Welcome to CYTOO!

We're currently working on a new website to reflect our current focus on muscle disorders!

_______________

In the meantime, please join us on LinkedIn.

However, you can still request quotes for micropattern products on our current website...

Noted, thank you!
  • Trademarks and Product Usage Info
  • Legal notice
  • Data protection policy
  • Cookies policy